Cardiovascular disease and lipids. Issues and evidence for the management of dyslipidaemia in primary care.
The commonest manifestations of cardiovascular disease, namely coronary heart disease (CHD) and stroke, represent the two most common causes of death in the world today. Furthermore, cardiovascular diseases have the highest healthcare utilisation costs in most countries. Both primary and secondary p...
Tác giả chính: | Hobbs, F |
---|---|
Định dạng: | Journal article |
Ngôn ngữ: | English |
Được phát hành: |
2003
|
Những quyển sách tương tự
-
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk
Bằng: article Editorial
Được phát hành: (2020-09-01) -
Effective management of dyslipidaemia among patients with cardiovascular risk: updated recommendations on identification and follow-up.
Bằng: Hobbs, R, et al.
Được phát hành: (2005) -
New Perspectives on Atherogenic Dyslipidaemia and Cardiovascular Disease
Bằng: Alberto J Lorenzatti, et al.
Được phát hành: (2020-02-01) -
2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)
Bằng: Mach, F, et al.
Được phát hành: (2019) -
Biochemical effects of statins on lipid parameters among newly diagnosed dyslipidaemia subjects in primary care
Bằng: Meor Anuar Shuhaili, Meor Fairuz Rizal, et al.
Được phát hành: (2018)